1140 PHASE I TRIAL OF A HIGHLY IMMUNOGENIC AND DURABLE T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL, RARE, ADENOVIRAL VECTORS

✍ Scribed by Barnes, E.; Folgori, A.; Capone, S.; Aston, S.; Meyer, J.; Gantlett, K.; Smith, K.E.; Huddart, R.; Brown, A.C.; Kurioka, A.; Humphreys, I.; Harrison, G.L.A.; Kelly, C.; Ammendola, V.; Colloca, S.; Naddeo, M.; Siani, L.; Traboni, C.; Córtese, R.; Nicosia, A.; Klenerman, P.

• Book ID: 123526006
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 59 KB
• Volume: 54
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(11)61142-2